Caveolin-1 regulates the anti-atherogenic properties of macrophages.

Stephanos Pavlides, Jorge L Gutierrez-Pajares, Sanjay Katiyar, Jean-François Jasmin, Isabelle Mercier, Rhonda Walters, Christos Pavlides, Richard G Pestell, Michael P Lisanti, Philippe G Frank

    Research output: Contribution to journalArticlepeer-review


    Atherosclerosis is a complex disease initiated by the vascular accumulation of lipoproteins in the sub-endothelial space, followed by the infiltration of monocytes into the arterial intima. Caveolin-1 (Cav-1) plays an essential role in the regulation of cellular cholesterol metabolism and of various signaling pathways. In order to study specifically the role of macrophage Cav-1 in atherosclerosis, we used Cav-1 (-/-) Apoe (-/-) mice and transplanted them with bone marrow (BM) cells obtained from Cav-1 (+/+) Apoe (-/-) or Cav-1 (-/-) Apoe (-/-) mice and vice versa. We found that Cav-1 (+/+) mice harboring Cav-1 (-/-) BM-derived macrophages developed significantly larger lesions than Cav-1 (+/+) mice harboring Cav-1 (+/+) BM-derived macrophages. Cav-1 (-/-) macrophages were more susceptible to apoptosis and more prone to induce inflammation. The present study provides clear evidence that the absence of Cav-1 in macrophage is pro-atherogenic, whereas its absence in endothelial cells protects against atherosclerotic lesion formation. These findings demonstrate the cell-specific role of Cav-1 during the development of this disease.
    Original languageEnglish
    JournalCell and Tissue Research
    Issue number3
    Publication statusPublished - Dec 2014


    Dive into the research topics of 'Caveolin-1 regulates the anti-atherogenic properties of macrophages.'. Together they form a unique fingerprint.

    Cite this